CU22414A1 - Fungicide composition - Google Patents
Fungicide compositionInfo
- Publication number
- CU22414A1 CU22414A1 CU1994007A CU1994007A CU22414A1 CU 22414 A1 CU22414 A1 CU 22414A1 CU 1994007 A CU1994007 A CU 1994007A CU 1994007 A CU1994007 A CU 1994007A CU 22414 A1 CU22414 A1 CU 22414A1
- Authority
- CU
- Cuba
- Prior art keywords
- activity
- protease
- type
- alacran
- baee
- Prior art date
Links
- 230000000855 fungicidal effect Effects 0.000 title 1
- 239000000417 fungicide Substances 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 abstract 3
- 239000004365 Protease Substances 0.000 abstract 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 abstract 2
- 240000003186 Stachytarpheta cayennensis Species 0.000 abstract 2
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical compound NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001050861 Rhopalurus junceus Species 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002949 hemolytic effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 230000001367 phospholipasic effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
ESTA INVENCION SE RELACIONA CON LAS RAMAS DE LA SALUD HUMANA Y ANIMAL, PARA EL TRATAMIENTO DE VARIOS TIPOS DE NEOPLASIAS. EL OBJETIVO TECNICO DE DICHA SOLUCION ES OBTENER UN PREPARADO FARMACEUTICO A PARTIR DE ALACRAN (RHOPALURUS JUNCEUS) QUE PRESENTA EFECTO ANTITUMORAL. LA ESENCIA DE LA INVENCION RADICA EN LA PREPARACION DE UN PRODUCTO FARMACEUTICO A PARTIR DEL ALACRAN, QUE TIENE ENTRE SUS COMPONENTES: CONCENTRACION DE PROTEINAS; ACTIVIDAD PROTEOLITICA: ACIDA NEUTRAL Y ALCALINA, Y ALCALINA (NEGATIVA): ACTIVIDAD INHIBIDORA DE PROTEASAS: FRENTE A PROTEASA DEL TIPO SERINO 18 UNIDADES BAEE.ML-1; FRENTE A PROTEASA DEL TIPO CISTEINO: 4 UNIDADES BAEE.ML 1, ACTIVIDAD FOSFOLIPASICA TIPO A2 1, 0,15A10-3; ACTIVIDAD HEMOLITICA (NEGATIVA). DICHO PRODUCTO PUEDE APLICARSE EN LA ESFERA DE LA ELABORACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE DIFERENTES TIPOS DE NEOPLASIAS.\!THIS INVENTION IS RELATED TO THE BRANCHES OF HUMAN AND ANIMAL HEALTH, FOR THE TREATMENT OF SEVERAL TYPES OF NEOPLASMS. THE TECHNICAL OBJECTIVE OF SUCH SOLUTION IS TO OBTAIN A PHARMACEUTICAL PREPARATION FROM ALACRAN (RHOPALURUS JUNCEUS) THAT PRESENTS ANTI-TUMORAL EFFECT. THE ESSENCE OF THE INVENTION IS IN THE PREPARATION OF A PHARMACEUTICAL PRODUCT FROM ALACRAN, WHICH HAS BETWEEN ITS COMPONENTS: PROTEIN CONCENTRATION; PROTEOLYTIC ACTIVITY: NEUTRAL AND ALKALINE ACID, AND ALKALINE (NEGATIVE): PROTEASE INHIBITING ACTIVITY: AGAINST SERINE TYPE PROTEASE 18 UNITS BAEE.ML-1; AGAINST PROTEASE OF THE CYSTEINE TYPE: 4 UNITS BAEE.ML 1, PHOSPHOLIPASIC ACTIVITY TYPE A2 1, 0.15A10-3; HEMOLYTIC ACTIVITY (NEGATIVE). SUCH PRODUCT MAY BE APPLIED IN THE FIELD OF PREPARING MEDICINES FOR THE TREATMENT OF DIFFERENT TYPES OF NEOPLASMS. \!
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1994007A CU22414A1 (en) | 1994-01-11 | 1994-01-11 | Fungicide composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1994007A CU22414A1 (en) | 1994-01-11 | 1994-01-11 | Fungicide composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU22414A1 true CU22414A1 (en) | 1996-01-31 |
Family
ID=5459163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1994007A CU22414A1 (en) | 1994-01-11 | 1994-01-11 | Fungicide composition |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU22414A1 (en) |
-
1994
- 1994-01-11 CU CU1994007A patent/CU22414A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69836822D1 (en) | Process for the treatment of capsules and dry powdered pharmaceutical formulations | |
| EP0693281A3 (en) | Pharmaceutical formulations containing fluoxetine | |
| GT199900069A (en) | GABAPENTINE STABILIZED PHARMACEUTICAL PREPARATIONS AND PROCESS TO PREPARE IT. | |
| EA200400482A1 (en) | KERATINOCYCES SUITABLE FOR APPLICATION AS A BIOLOGICALLY ACTIVE SUBSTANCE IN THE TREATMENT OF THE RAS | |
| ECSP034883A (en) | AMIDAS OF ANTRANILIC ACIDS WITH SIDE CHAIN OF HETEROARILSULFONILO, PROCEDURE FOR THEIR PREPARATION, ITS EMPLOYMENT AS A MEDICINAL OR DIAGNOSTIC AGENT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| ES2178048T3 (en) | USE OF RIFAXIMINE AS A MEDICINAL PRODUCT FOR THE TREATMENT OF DIARRHEA BY CRYPTOSPORIDIOSIS. | |
| ES2178779T3 (en) | NEW AMIDAS OF PIRIDIL ALCANS ACIDS AS CYTOSTATIC AGENTS AND IMMUNOSUPPRESSORS. | |
| FR2453650A1 (en) | MEDICAMENT BASED ON CHOLECALCIFEROL DERIVATIVES, USEFUL FOR ADJUSTING BONE METABOLISM IN HOMEOTHERMES | |
| RU94006580A (en) | Adaptogen trecresan in medicine | |
| DE602004016403D1 (en) | Topical pharmaceutical compositions containing active natural ingredients for the prevention and treatment of mucosal inflammatory processes | |
| EP1604659A4 (en) | COMPRESSOR CONTAINING AN AMINO ACID ABSORBING WATER | |
| ATE340561T1 (en) | USE OF ANTISEPTICS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE PROPHYLAXIS AND TREATMENT OF INFLAMMATION INSIDE THE HUMAN BODY | |
| CN103463967A (en) | Special-purpose formaldehyde scavenging agent for air purifier | |
| ES2111175T3 (en) | PIPERAZINES 1,4-DISSTITUTED USEFUL IN THE TREATMENT OF ASTHMA AND INFLAMMATION OF THE RESPIRATORY TRACT. | |
| TR200100637T2 (en) | New natural product derivatives | |
| CU22413A1 (en) | Antitumorigenic composition | |
| CU22414A1 (en) | Fungicide composition | |
| ATE152350T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 5-DIFLUOROMETHOXY-2-(3,4-DIMETHOXY-2-PYRIDYL)METHYLSULFINYL>-1H-BENZIMIDAZOLE AND AN ANTI-HELIOBACTER FOR THE TREATMENT OF GASTROINTESTINAL DISEASES | |
| ATE205399T1 (en) | A STORAGE-Stable AQUEOUS INFUSION SOLUTION CONTAINING A THROMBIN INHIBITOR | |
| ATE197545T1 (en) | USE OF ASPIRIN IN THE PRODUCTION OF A MEDICINAL PRODUCT TO IMPROVE BLOOD PERFUSION OF THE uterus | |
| ATE390121T1 (en) | MICELLE COMPOSITIONS CONTAINING PEGYLATED PHOSPHOLIPIDES AND A PHOTOSENSITISER | |
| ES2175582T3 (en) | CHROMANS SUBSTITUTED WITH SULFONAMIDE, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL PRODUCT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| RU2232711C1 (en) | Method of production of xenon difluoride, its rectification and application | |
| RU2243152C2 (en) | Xenon hexafluoride-boron trifluoride complex preparation method and utilization thereof | |
| AR010950A1 (en) | METHODS OF TREATMENT OF DRY AND SPRAY CAPSULES AND PHARMACEUTICAL FORMULATIONS. |